Single-cell Cerebrospinal Fluid Transcriptome Profiling Suggests Dysfunctional Boarder Associated Macrophages Underlying Progression Independent of Relapse Activity in Multiple Sclerosis

Trajectories of Serum NfL and GFAP Levels in Newly Diagnosed Multiple Sclerosis Patients After Initiation of Immunomodulatory Treatments